Critical Roles for Lipomannan and Lipoarabinomannan in Cell Wall Integrity of Mycobacteria and Pathogenesis of Tuberculosis

Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a bra...

Full description

Saved in:
Bibliographic Details
Published inmBio Vol. 4; no. 1; p. e00472
Main Authors Fukuda, Takeshi, Matsumura, Takayuki, Ato, Manabu, Hamasaki, Maho, Nishiuchi, Yukiko, Murakami, Yoshiko, Maeda, Yusuke, Yoshimori, Tamotsu, Matsumoto, Sohkichi, Kobayashi, Kazuo, Kinoshita, Taroh, Morita, Yasu S.
Format Journal Article
LanguageEnglish
Published United States American Society of Microbiology 01.03.2013
American Society for Microbiology
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis , structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target. Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target.
AbstractList ABSTRACT Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis, structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target.
Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis, structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target.Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis, structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target.
Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis , structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target.
Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis , structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target.
Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations, the significance of LM and LAM as structural components of the mycobacterial cell wall remains unknown. We have previously reported that a branch-forming mannosyltransferase plays a critical role in controlling the sizes of LM and LAM and that deletion or overexpression of this enzyme results in gross changes in LM/LAM structures. Here, we show that such changes in LM/LAM structures have a significant impact on the cell wall integrity of mycobacteria. In Mycobacterium smegmatis , structural defects in LM and LAM resulted in loss of acid-fast staining, increased sensitivity to β-lactam antibiotics, and faster killing by THP-1 macrophages. Furthermore, equivalent Mycobacterium tuberculosis mutants became more sensitive to β-lactams, and one mutant showed attenuated virulence in mice. Our results revealed previously unknown structural roles for LM and LAM and further demonstrated that they are important for the pathogenesis of tuberculosis. IMPORTANCE Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target. Tuberculosis (TB) is a global burden, affecting millions of people worldwide. Mycobacterium tuberculosis is a causative agent of TB, and understanding the biology of M. tuberculosis is essential for tackling this devastating disease. The cell wall of M. tuberculosis is highly impermeable and plays a protective role in establishing infection. Among the cell wall components, LM and LAM are major glycolipids found in all Mycobacterium species, show various immunomodulatory activities, and have been thought to play roles in TB pathogenesis. However, the roles of LM and LAM as integral parts of the cell wall structure have not been elucidated. Here we show that LM and LAM play critical roles in the integrity of mycobacterial cell wall and the pathogenesis of TB. These findings will now allow us to seek the possibility that the LM/LAM biosynthetic pathway is a chemotherapeutic target.
Author Morita, Yasu S.
Murakami, Yoshiko
Kinoshita, Taroh
Fukuda, Takeshi
Ato, Manabu
Maeda, Yusuke
Matsumura, Takayuki
Yoshimori, Tamotsu
Kobayashi, Kazuo
Hamasaki, Maho
Nishiuchi, Yukiko
Matsumoto, Sohkichi
Author_xml – sequence: 1
  givenname: Takeshi
  surname: Fukuda
  fullname: Fukuda, Takeshi
  organization: Research Institute for Microbial Diseases, WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan
– sequence: 2
  givenname: Takayuki
  surname: Matsumura
  fullname: Matsumura, Takayuki
  organization: Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 3
  givenname: Manabu
  surname: Ato
  fullname: Ato, Manabu
  organization: Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 4
  givenname: Maho
  surname: Hamasaki
  fullname: Hamasaki, Maho
  organization: Department of Genetics, Graduate School of Medicine, Osaka University, Osaka, Japan
– sequence: 5
  givenname: Yukiko
  surname: Nishiuchi
  fullname: Nishiuchi, Yukiko
  organization: Department of Bacteriology, Osaka City University Graduate School of Medicine, Osaka, Japan
– sequence: 6
  givenname: Yoshiko
  surname: Murakami
  fullname: Murakami, Yoshiko
  organization: Research Institute for Microbial Diseases, WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan
– sequence: 7
  givenname: Yusuke
  surname: Maeda
  fullname: Maeda, Yusuke
  organization: Research Institute for Microbial Diseases, WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan
– sequence: 8
  givenname: Tamotsu
  surname: Yoshimori
  fullname: Yoshimori, Tamotsu
  organization: Department of Genetics, Graduate School of Medicine, Osaka University, Osaka, Japan
– sequence: 9
  givenname: Sohkichi
  surname: Matsumoto
  fullname: Matsumoto, Sohkichi
  organization: Department of Bacteriology, Osaka City University Graduate School of Medicine, Osaka, Japan
– sequence: 10
  givenname: Kazuo
  surname: Kobayashi
  fullname: Kobayashi, Kazuo
  organization: Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 11
  givenname: Taroh
  surname: Kinoshita
  fullname: Kinoshita, Taroh
  organization: Research Institute for Microbial Diseases, WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan
– sequence: 12
  givenname: Yasu S.
  surname: Morita
  fullname: Morita, Yasu S.
  organization: Research Institute for Microbial Diseases, WPI-Immunology Frontier Research Center, Osaka University, Osaka, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23422411$$D View this record in MEDLINE/PubMed
BookMark eNqFkt9rFDEQxxep2Fr76Kvsoy9bk0ku2X0R9PDHwYkiFR_D5MdeU_aSM9kVDv95s3dtsYKYh2Rm8pkvk8k8rU5CDK6qnlNySSm0r7ZvfbwkhEtoKDyqzoAuSCMXlJ7MtqANUOhOq4ucb0hZjNGWkSfVKTAOwCk9q34tkx-9waH-GgeX6z6meu13cYshYKgx2IOLCbUPd1Ef6qUbhvo7lm0VRrcpIvs69vWnvYkazeiSx0PyFxyv48YFl32egatJu2SmIRb_WfW4xyG7i9vzvPr2_t3V8mOz_vxhtXyzbowAGBvotOZOgJEEuFx0zHZg0VItKAime9sa7nhPrSVMdgXpLXZAdNshLGxP2Xm1OuraiDdql_wW015F9OoQiGmjMJUmDE5JwaUgoA0xjrdti8XrLSOtlkJAz4rW66PWbtJbZ40LY8LhgejDm-Cv1Sb-VGwhmRBzMS9vBVL8Mbk8qq3PpnQTg4tTVlRywSSRHfs_Ch0VhHLeFfTFn2Xd13P30QVojoBJMefk-nuEEjXPkppnSR1mqQgXnv3FGz_i6OP8Kj_8I-s3HdLN4w
CitedBy_id crossref_primary_10_1038_s41467_023_41431_2
crossref_primary_10_1016_j_compbiomed_2025_109677
crossref_primary_10_3389_fimmu_2017_01659
crossref_primary_10_1021_acssensors_8b00393
crossref_primary_10_1016_j_tube_2018_09_007
crossref_primary_10_1128_mbio_00322_25
crossref_primary_10_1093_femsre_fuz006
crossref_primary_10_1186_s12917_019_2114_3
crossref_primary_10_3389_fimmu_2014_00455
crossref_primary_10_3390_ijms241914942
crossref_primary_10_1038_s41579_019_0273_7
crossref_primary_10_1093_femspd_fty026
crossref_primary_10_1016_j_tube_2022_102165
crossref_primary_10_4103_ijmr_IJMR_2055_16
crossref_primary_10_1371_journal_ppat_1004542
crossref_primary_10_1128_spectrum_03197_22
crossref_primary_10_3390_biom10030357
crossref_primary_10_1038_s41467_024_46565_5
crossref_primary_10_1016_j_cbpa_2021_05_009
crossref_primary_10_1021_jacs_3c09495
crossref_primary_10_1128_mBio_01823_17
crossref_primary_10_3390_ijms20246244
crossref_primary_10_2217_fmb_2017_0135
crossref_primary_10_1039_C5MB00476D
crossref_primary_10_1002_iub_1331
crossref_primary_10_1016_j_jgg_2021_05_004
crossref_primary_10_1371_journal_pone_0113101
crossref_primary_10_1093_glycob_cwad096
crossref_primary_10_3390_ijms21196979
crossref_primary_10_1021_acsinfecdis_9b00008
crossref_primary_10_1111_sji_13261
crossref_primary_10_1042_BCJ20200194
crossref_primary_10_1099_mic_0_000605
crossref_primary_10_1128_mSphere_01039_20
crossref_primary_10_1186_s12864_015_1569_2
crossref_primary_10_3109_10409238_2014_925420
crossref_primary_10_1016_j_ebiom_2016_05_041
crossref_primary_10_1016_j_jlr_2024_100533
crossref_primary_10_1128_mbio_03396_22
crossref_primary_10_1016_j_tcsw_2022_100088
crossref_primary_10_3390_antibiotics10060693
crossref_primary_10_1016_j_apsb_2025_01_023
crossref_primary_10_1016_j_tube_2015_02_028
crossref_primary_10_1128_mSphere_00245_21
crossref_primary_10_1074_jbc_M117_804377
crossref_primary_10_1002_mas_21530
crossref_primary_10_1111_cmi_12175
crossref_primary_10_1021_acs_jmedchem_1c01870
crossref_primary_10_1093_glycob_cwab022
crossref_primary_10_1021_acs_joc_9b03064
crossref_primary_10_3390_cells11030361
crossref_primary_10_1128_JB_01346_13
crossref_primary_10_1126_scisignal_aaf1585
crossref_primary_10_3390_app10072278
crossref_primary_10_1021_acsabm_2c00026
crossref_primary_10_1002_jcla_25122
crossref_primary_10_1016_j_mib_2021_01_012
crossref_primary_10_1128_microbiolspec_TBTB2_0003_2015
crossref_primary_10_3389_fmicb_2023_1236599
crossref_primary_10_1093_femsle_fny025
crossref_primary_10_1016_j_bbalip_2016_11_002
crossref_primary_10_1128_JB_00419_21
crossref_primary_10_3389_fvets_2021_615029
crossref_primary_10_1016_j_ijbiomac_2024_129583
crossref_primary_10_1038_s41467_024_50051_3
crossref_primary_10_1016_j_jconrel_2023_07_013
crossref_primary_10_1016_j_jgg_2019_12_002
crossref_primary_10_3389_fcimb_2014_00187
crossref_primary_10_1016_j_micpath_2019_01_013
crossref_primary_10_1038_nature25177
crossref_primary_10_1007_s00430_016_0470_1
crossref_primary_10_1016_j_drudis_2016_09_025
crossref_primary_10_3390_separations9100271
crossref_primary_10_1080_14787210_2023_2224563
crossref_primary_10_1186_s12916_016_0603_9
crossref_primary_10_4049_jimmunol_1701673
crossref_primary_10_1021_acsinfecdis_4c00079
crossref_primary_10_3389_fcimb_2025_1498651
crossref_primary_10_1038_s41598_020_62287_2
crossref_primary_10_1021_acs_chemrev_1c00729
crossref_primary_10_3389_fimmu_2022_849321
crossref_primary_10_1016_j_nano_2014_02_012
crossref_primary_10_1016_j_tube_2019_02_008
crossref_primary_10_1016_j_cll_2020_08_010
crossref_primary_10_1007_s00284_017_1393_9
crossref_primary_10_1038_s42004_020_00356_3
Cites_doi 10.1128/AAC.44.10.2845-2847.2000
10.1128/AAC.39.12.2620
10.1128/JB.186.20.6792-6799.2004
10.1128/AAC.00647-09
10.1073/pnas.85.18.6987
10.1074/jbc.M604214200
10.1038/nrmicro1861
10.1074/jbc.M511709200
10.1111/j.1365-2958.2004.04183.x
10.1016/S0021-9258(18)42686-5
10.1128/JB.00216-07
10.1074/jbc.M303446200
10.1074/jbc.M703389200
10.1128/JB.185.24.7103-7110.2003
10.1093/glycob/3.5.497
10.1016/S1472-9792(02)00089-6
10.1016/j.tube.2008.04.002
10.1111/j.1574-6976.2011.00276.x
10.1074/jbc.M603395200
10.1128/JB.01825-07
10.1016/j.bbagen.2011.03.017
10.1016/S0065-2164(09)69002-X
10.1073/pnas.0603049103
10.1046/j.1365-2958.2003.03425.x
10.1128/IAI.00974-07
10.1074/jbc.M109.077297
10.1016/S0021-9258(18)42685-3
10.1111/j.1462-5822.2007.01097.x
10.1002/path.1700580320
10.1074/jbc.R110.168328
10.1074/jbc.M806350200
10.1371/journal.pone.0015857
10.1111/j.1365-2818.2009.03299.x
10.1042/bj20031372
10.1073/pnas.0807761105
10.1016/j.tube.2010.02.003
10.1093/glycob/cwp042
10.1074/jbc.M109.049635
10.1111/j.1365-2958.2007.05884.x
10.1128/jb.8.2.121-126.1923
10.1016/S0021-9258(18)31404-2
10.1099/mic.0.27629-0
ContentType Journal Article
Copyright Copyright © 2013 Fukuda et al. 2013 Fukuda et al.
Copyright_xml – notice: Copyright © 2013 Fukuda et al. 2013 Fukuda et al.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOA
DOI 10.1128/mBio.00472-12
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
MEDLINE - Academic
AGRICOLA

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Role of Mycobacterial Mannan in Pathogenesis
EISSN 2150-7511
ExternalDocumentID oai_doaj_org_article_7647602bc0ce4888a760fd308b7662f3
PMC3573661
23422411
10_1128_mBio_00472_12
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
53G
5VS
AAFWJ
AAGFI
AAUOK
AAYXX
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BTFSW
C1A
CITATION
DIK
E3Z
EBS
EJD
FRP
GROUPED_DOAJ
GX1
H13
HYE
HZ~
KQ8
M48
O5R
O5S
O9-
OK1
P2P
PGMZT
RHI
RNS
RPM
RSF
CGR
CUY
CVF
ECM
EIF
M~E
NPM
RHF
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c622t-29bb4e62c70247593d92dad1b61263bfd8c4e4f1dd0379247fda920b89a25df13
IEDL.DBID M48
ISSN 2161-2129
2150-7511
IngestDate Wed Aug 27 01:31:27 EDT 2025
Thu Aug 21 14:14:21 EDT 2025
Fri Jul 11 08:07:51 EDT 2025
Thu Jul 10 23:36:17 EDT 2025
Wed Feb 19 02:31:33 EST 2025
Tue Jul 01 01:52:21 EDT 2025
Thu Apr 24 23:06:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c622t-29bb4e62c70247593d92dad1b61263bfd8c4e4f1dd0379247fda920b89a25df13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Invited Editor William Bishai, Johns Hopkins University School of Medicine
T.F. and T.M. contributed equally to this work.
Present address: Yasu S. Morita, Department of Microbiology, University of Massachusetts, Amherst, Massachusetts, USA.
Editor Keith Klugman, Emory University
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1128/mBio.00472-12
PMID 23422411
PQID 1291601449
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_7647602bc0ce4888a760fd308b7662f3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3573661
proquest_miscellaneous_1746370793
proquest_miscellaneous_1291601449
pubmed_primary_23422411
crossref_primary_10_1128_mBio_00472_12
crossref_citationtrail_10_1128_mBio_00472_12
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20130301
PublicationDateYYYYMMDD 2013-03-01
PublicationDate_xml – month: 03
  year: 2013
  text: 20130301
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle mBio
PublicationTitleAlternate mBio
PublicationYear 2013
Publisher American Society of Microbiology
American Society for Microbiology
Publisher_xml – name: American Society of Microbiology
– name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
Schlesinger LS (e_1_3_2_25_2) 2008
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_46_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_14_2
e_1_3_2_35_2
World Health Organization (e_1_3_2_2_2) 2011
Gilleron M (e_1_3_2_24_2) 2008
References_xml – ident: e_1_3_2_34_2
  doi: 10.1128/AAC.44.10.2845-2847.2000
– ident: e_1_3_2_31_2
  doi: 10.1128/AAC.39.12.2620
– ident: e_1_3_2_46_2
  doi: 10.1128/JB.186.20.6792-6799.2004
– ident: e_1_3_2_41_2
  doi: 10.1128/AAC.00647-09
– ident: e_1_3_2_39_2
  doi: 10.1073/pnas.85.18.6987
– ident: e_1_3_2_13_2
  doi: 10.1074/jbc.M604214200
– ident: e_1_3_2_36_2
  doi: 10.1038/nrmicro1861
– ident: e_1_3_2_12_2
  doi: 10.1074/jbc.M511709200
– ident: e_1_3_2_23_2
  doi: 10.1111/j.1365-2958.2004.04183.x
– ident: e_1_3_2_19_2
  doi: 10.1016/S0021-9258(18)42686-5
– ident: e_1_3_2_45_2
  doi: 10.1128/JB.00216-07
– ident: e_1_3_2_5_2
  doi: 10.1074/jbc.M303446200
– ident: e_1_3_2_8_2
  doi: 10.1074/jbc.M703389200
– ident: e_1_3_2_35_2
  doi: 10.1128/JB.185.24.7103-7110.2003
– ident: e_1_3_2_18_2
  doi: 10.1093/glycob/3.5.497
– volume-title: Global tuberculosis control: WHO report 2011
  year: 2011
  ident: e_1_3_2_2_2
– ident: e_1_3_2_3_2
  doi: 10.1016/S1472-9792(02)00089-6
– ident: e_1_3_2_4_2
  doi: 10.1016/j.tube.2008.04.002
– ident: e_1_3_2_11_2
  doi: 10.1111/j.1574-6976.2011.00276.x
– ident: e_1_3_2_21_2
  doi: 10.1074/jbc.M603395200
– start-page: 75
  volume-title: The mycobacterial cell envelope
  year: 2008
  ident: e_1_3_2_24_2
– ident: e_1_3_2_27_2
  doi: 10.1128/JB.01825-07
– ident: e_1_3_2_6_2
  doi: 10.1016/j.bbagen.2011.03.017
– ident: e_1_3_2_10_2
  doi: 10.1016/S0065-2164(09)69002-X
– ident: e_1_3_2_14_2
  doi: 10.1073/pnas.0603049103
– ident: e_1_3_2_22_2
  doi: 10.1046/j.1365-2958.2003.03425.x
– ident: e_1_3_2_30_2
  doi: 10.1128/IAI.00974-07
– ident: e_1_3_2_15_2
  doi: 10.1074/jbc.M109.077297
– start-page: 1
  volume-title: Handbook of tuberculosis: immunology and cell biology
  year: 2008
  ident: e_1_3_2_25_2
– ident: e_1_3_2_7_2
  doi: 10.1016/S0021-9258(18)42685-3
– ident: e_1_3_2_38_2
  doi: 10.1111/j.1462-5822.2007.01097.x
– ident: e_1_3_2_32_2
  doi: 10.1002/path.1700580320
– ident: e_1_3_2_9_2
  doi: 10.1074/jbc.R110.168328
– ident: e_1_3_2_37_2
  doi: 10.1074/jbc.M806350200
– ident: e_1_3_2_44_2
  doi: 10.1371/journal.pone.0015857
– ident: e_1_3_2_40_2
  doi: 10.1111/j.1365-2818.2009.03299.x
– ident: e_1_3_2_43_2
  doi: 10.1042/bj20031372
– ident: e_1_3_2_16_2
  doi: 10.1073/pnas.0807761105
– ident: e_1_3_2_26_2
  doi: 10.1016/j.tube.2010.02.003
– ident: e_1_3_2_28_2
  doi: 10.1093/glycob/cwp042
– ident: e_1_3_2_29_2
  doi: 10.1074/jbc.M109.049635
– ident: e_1_3_2_17_2
  doi: 10.1111/j.1365-2958.2007.05884.x
– ident: e_1_3_2_42_2
  doi: 10.1128/jb.8.2.121-126.1923
– ident: e_1_3_2_20_2
  doi: 10.1016/S0021-9258(18)31404-2
– ident: e_1_3_2_33_2
  doi: 10.1099/mic.0.27629-0
SSID ssj0000331830
Score 2.3649392
Snippet Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune modulations,...
ABSTRACT Lipomannan (LM) and lipoarabinomannan (LAM) are mycobacterial glycolipids containing a long mannose polymer. While they are implicated in immune...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e00472
SubjectTerms Animals
Anti-Bacterial Agents - pharmacology
beta-lactam antibiotics
beta-lactams
beta-Lactams - pharmacology
biochemical pathways
Cell Wall - metabolism
Cell Wall - physiology
cell wall components
cell walls
drug therapy
Female
glycolipids
immunomodulation
Lipopolysaccharides - metabolism
macrophages
Macrophages - immunology
Macrophages - microbiology
mannose
Mice
Mice, Inbred C57BL
Microbial Viability
mutants
Mycobacterium smegmatis
Mycobacterium smegmatis - drug effects
Mycobacterium smegmatis - metabolism
Mycobacterium smegmatis - pathogenicity
Mycobacterium smegmatis - physiology
Mycobacterium tuberculosis
Mycobacterium tuberculosis - drug effects
Mycobacterium tuberculosis - metabolism
Mycobacterium tuberculosis - pathogenicity
Mycobacterium tuberculosis - physiology
pathogenesis
people
polymers
protective effect
tuberculosis
Tuberculosis - microbiology
virulence
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhUOiltOlr06aoEHqqG-thyT42ISEtSSklgdyMnq1hI4fN7iH0z3dGXi-7oY9Lj5LHtqQZab6xh28I2be1C7KKttCYHCZ1ZIVRzBQBXIUWjcEQA7MtvqjTS_n5qrpaK_WFOWEDPfCwcAdaSa1Kbl0JD4VwzUArelHWVivFY-b5BJ-3FkzlM1igrZYjqSavD64Pu_5D5kYsGN9wQpmr_3cA836e5JrjOXlMHi0RI_04jPQJ2QpphzwYakjePSU_x2IF9BtyM1EAofSsu-mvTUomUZN8bpqZgRh47O0SPQrTKcXP6PRTZowANE77SM_vHOzwzOBs8s1fASL23_FE7G5R4GJhw8wtpj20n5HLk-OLo9NiWVGhcIrzecEba2VQ3GlwzbpqhG-4N55ZwDlK2OhrJ4OMzPtSaIjMdPSm4aWtQWmVj0w8J9upT-Elob5y3NSRhTJIGT3gTF6XNvAm2qiZZxPyflzi1i3pxrHqxbTNYQevW9RImzXSMj4h71biNwPPxp8ED1FfKyGkx84dYDTt0mjafxnNhLwdtd3CdsJ_JCaFfnELLwC8jFFm8xcZLZXIzIIT8mKwkNVwuJAIimD6esN2Nsa7eSV1PzKtt6i0ALS0-z8m-Io85LluBybLvSbb89ki7AF6mts3eaP8ArKbGR0
  priority: 102
  providerName: Directory of Open Access Journals
Title Critical Roles for Lipomannan and Lipoarabinomannan in Cell Wall Integrity of Mycobacteria and Pathogenesis of Tuberculosis
URI https://www.ncbi.nlm.nih.gov/pubmed/23422411
https://www.proquest.com/docview/1291601449
https://www.proquest.com/docview/1746370793
https://pubmed.ncbi.nlm.nih.gov/PMC3573661
https://doaj.org/article/7647602bc0ce4888a760fd308b7662f3
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9NAEF_kRPBF_DZ-HCuIT-bMfiSbPIh44nkI-mShb2E3u3sG2s1d2qLFf96ZTVLtcedLYNNJG3ZmMr8J09-PkFembJzMvUkVDodJ5VmqC6ZTB6VCiUpji4HTFt-K05n8Ms_nfymFxg1cXdnaoZ7UrF8c_brYvoeEfzf8AaZ8uzxuu6NIe5ii3vBNKEoKxQy-jkg_PpQFBm82sWxevgo5gYXEcsb2ClTk8b8KfF6eofynKJ3cJXdGNEk_DO6_R264cJ_cGvQltw_I70nIgOIQ4YoCQKWL9rxb6hB0oDrYuNS9hv54OtsGim_z6U8Nh4FNApA67TxdbhvI_sjurOPFKGfcneHTsl2hwXpjXN9sFh2sH5LZyafvH0_TUW0hbQrO1ymvjJGu4I2Csq3yStiKW22ZAQxUCONt2UgnPbM2Ewq6NuWtrnhmSnBobj0Tj8hB6IJ7QqjNG65Lz1zmpPQWMCgvM-N45Y1XzLKEvJm2uG5GKnJUxFjUsSXhZY3OqaNzasYT8npnfj5wcFxneIz-2hkhdXY80fVn9ZiJtSqkKjJumgyiFPp_DStvRVYaVRTci4S8nLxdQ6rhjuvgus0KfgCwNHag1X9slCxEZB1MyOMhQna3M0VYQtRe7Ozd7_4nof0RKb9FrgQgqafXfuczcptHoQ6cjntODtb9xr0AuLQ2h_E1Axw_z9lhTIo_EwMW7Q
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Critical+roles+for+lipomannan+and+lipoarabinomannan+in+cell+wall+integrity+of+mycobacteria+and+pathogenesis+of+tuberculosis&rft.jtitle=mBio&rft.au=Fukuda%2C+Takeshi&rft.au=Matsumura%2C+Takayuki&rft.au=Ato%2C+Manabu&rft.au=Hamasaki%2C+Maho&rft.date=2013-03-01&rft.eissn=2150-7511&rft.volume=4&rft.issue=1&rft.spage=e00472&rft_id=info:doi/10.1128%2FmBio.00472-12&rft_id=info%3Apmid%2F23422411&rft.externalDocID=23422411
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2161-2129&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2161-2129&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2161-2129&client=summon